These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7930866)

  • 1. Are there effective treatments for the severely obese?
    Martin LF; Hunter SM
    J La State Med Soc; 1994 Aug; 146(8):348-54. PubMed ID: 7930866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Health risks and economic costs associated with obesity requiring a comprehensive weight reduction program].
    Hainer V; Kunesová M; Parízková J; Stunkard A
    Cas Lek Cesk; 1997 Jun; 136(12):367-72. PubMed ID: 9333508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weighing the options: criteria for evaluating weight-management programs. The Committee to Develop Criteria for Evaluating the Outcomes of Approaches to Prevent and Treat Obesity.
    Stern JS; Hirsch J; Blair SN; Foreyt JP; Frank A; Kumanyika SK; Madans JH; Marlatt GA; St Jeor ST; Stunkard AJ
    Obes Res; 1995 Nov; 3(6):591-604. PubMed ID: 8653537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health economics of weight management: evidence and cost.
    Kouris-Blazos A; Wahlqvist ML
    Asia Pac J Clin Nutr; 2007; 16 Suppl 1():329-38. PubMed ID: 17392129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The economic impact of obesity. Building bridges with managed care.
    Wolf AM
    Postgrad Med; 2001 Jun; 109(6 Suppl):34-9. PubMed ID: 19667566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Direct medical costs of (severe) obesity: a bottom-up assessment of over- vs. normal-weight adults in the KORA-study region (Augsburg, Germany)].
    von Lengerke T; Reitmeir P; John J
    Gesundheitswesen; 2006 Feb; 68(2):110-5. PubMed ID: 16482491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost of obesity in Canada.
    Birmingham CL; Muller JL; Palepu A; Spinelli JJ; Anis AH
    CMAJ; 1999 Feb; 160(4):483-8. PubMed ID: 10081464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic burden of obesity-related chronic diseases in Mainland China.
    Zhao W; Zhai Y; Hu J; Wang J; Yang Z; Kong L; Chen C
    Obes Rev; 2008 Mar; 9 Suppl 1():62-7. PubMed ID: 18307701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment modalities of obesity: what fits whom?
    Hainer V; Toplak H; Mitrakou A
    Diabetes Care; 2008 Feb; 31 Suppl 2():S269-77. PubMed ID: 18227496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits of sustained moderate weight loss in obesity.
    Pasanisi F; Contaldo F; de Simone G; Mancini M
    Nutr Metab Cardiovasc Dis; 2001 Dec; 11(6):401-6. PubMed ID: 12055705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hand-assisted laparoscopic gastric bypass does not improve outcome and increases costs when compared to open gastric bypass for the surgical treatment of obesity.
    DeMaria EJ; Schweitzer MA; Kellum JM; Meador J; Wolfe L; Sugerman HJ
    Surg Endosc; 2002 Oct; 16(10):1452-5. PubMed ID: 12063573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomedical engineering and the obesity epidemic: treatments for weight reduction.
    Rutherford JJ
    IEEE Eng Med Biol Mag; 2010; 29(1):24-30. PubMed ID: 20176518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in prescription medication costs after laparoscopic gastric bypass.
    Nguyen NT; Varela JE; Sabio A; Naim J; Stamos M; Wilson SE
    Am Surg; 2006 Oct; 72(10):853-6. PubMed ID: 17058720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity and disease management: effects of weight loss on comorbid conditions.
    Anderson JW; Konz EC
    Obes Res; 2001 Nov; 9 Suppl 4():326S-334S. PubMed ID: 11707561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current methods used for defining, measuring, and treating obesity.
    Moyad MA
    Semin Urol Oncol; 2001 Nov; 19(4):247-56. PubMed ID: 11769877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future and implications of reimbursement for obesity treatment.
    Stern JS; Kazaks A; Downey M
    J Am Diet Assoc; 2005 May; 105(5 Suppl 1):S104-9. PubMed ID: 15867905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laparoscopic gastric bypass: risks vs. benefits up to two years following surgery in super-super obese patients.
    Gould JC; Garren MJ; Boll V; Starling JR
    Surgery; 2006 Oct; 140(4):524-9; discussion 529-31. PubMed ID: 17011899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass.
    Gómez-Ambrosi J; Rodríguez A; Catalán V; Ramírez B; Silva C; Rotellar F; Gil MJ; Salvador J; Frühbeck G
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):208-15. PubMed ID: 18081728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension in obesity.
    Redon J
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):344-53. PubMed ID: 11887431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 25-year health care costs of women who remain overweight after 40 years of age.
    Gorsky RD; Pamuk E; Williamson DF; Shaffer PA; Koplan JP
    Am J Prev Med; 1996; 12(5):388-94. PubMed ID: 8909650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.